2m 2m 2m 2m 2m 2m 2m
Acadia Pharma (ACAD)
NASDAQ
$26.05+$0.18 (+0.68%)
Price as of Aug 03, 2026 6:16 AM EDT- $4.4BMarket Cap
- 9.94%1-Year Change
- BiotechnologyIndustry
Acadia Pharma (ACAD)
$26.05+$0.18 (+0.68%)
ACAD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $25.87 | ||
Change | -$0.68 (-2.56%) | ||
Open | $26.44 | ||
High | $26.44 | ||
Low | $25.34 | ||
Previous Close | $26.55 | ||
Volume | 1,534,224 | ||
30-Day Average Volume | 1,421,911 | ||
1-Week Change | 4.15% | ||
1-Month Change | 2.25% | ||
1-Year Change | 9.94% | ||
3-Year Change | -11.53% | ||
5-Year Change | 19.60% | ||
Fundamentals | |||
Shares Outstanding | 171.2M | ||
Total Assets | $1.6B | ||
Market Cap | $4.4B | ||
Enterprise Value | $4.1B | ||
Period: QTR TTM FY | |||
Revenue | $268.1M | ||
Net Income | $3.6M | ||
Free Cash Flow | $28.8M | ||
EBIT | $4.0M | ||
EBITDA | $6.7M | ||
Net Working Capital | $790.5M | ||
EPS | $0.02 | ||
Enterprise Value/EBITDA | 619 | ||
Enterprise Value/Revenue | 15 | ||
P/B | 4 | ||
P/E | 1,294 | ||
PEG | -13 | ||
Price/Free Cash Flow | 154 | ||
Price/Operating Cash Flow | 130 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue